Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

Jacob Tveiten Bjerrum^*, Casper Steenholdt, Mark Ainsworth, Ole Haagen Nielsen, Michelle A.C. Reed, Karen Atkins, Ulrich Leonhard Günther, Fuhua Hao, Yulan Wang

^*Corresponding author af dette arbejde